General Manager - (AF279 - MUSh-2528-482-1)
Job Brief:Position: General ManagerLocation: Tweed Heads, NSWJob type: Full Time, 38 hours/weekSalary range: AUD 180,500The General Manager holds overall responsibility for the leadership, growth, and day-to-day management of GC Vivablast Australia (GCVBA).…
Vice President & General Manager, Australia
Revolution Medicines is a global, commercial-state oncology company dedicated to discovering, developing and delivering innovative medicines for patients with RAS-addicted cancers. Leveraging its differentiated RAS(ON) tri-complex inhibitor platform, the compa…
General Manager - Service Delivery
Company DescriptionHave you ever thought, “I want the work I do to be meaningful”?At atWork Australia, that’s exactly what you’ll find because we believe work’s for everyone.We connect people and business so both can thrive. Since 2003, atWork Austra…
General Manager | Residential Aged Care (Sienna Grange)
General Manager | Residential Aged Care (Sienna Grange)Australian Unity Limited - Port Macquarie, NSWHealth, Medical & PharmaceuticalSource: uWorkinJOB DESCRIPTIONJob DescriptionLead the overall operational performance of Sienna Grange Residential Aged CareDri…
General Manager – Rhema 99.9
Rhema 99.9 is preparing for an important new chapter and is seeking expressions of interest from an experienced, values-driven leader for the proposed position of General Manager.Location: Port Macquarie, NSWEmployment Type: 4-days per weekStatus: Expression o…
Strategic General Manager - Community Radio Leader (4-Day)
Rhema 99.9 in Port Macquarie seeks an experienced, values-driven General Manager to lead during a major leadership transition. Working with the Board and staff, you will steer strategy, governance and community engagement while ensuring continuity of service.D…
Vice President & General Manager, Australia
Job DescriptionRevolution Medicines is a global, commercial-state oncology company dedicated to discovering, developing and delivering innovative medicines for patients with RAS-addicted cancers. Leveraging its differentiated RAS(ON) tri-complex inhibitor plat…